FilingSEC EDGAR6-K
Satellos Bioscience Announces INN for Lead Drug Candidate
· SEC accepted
Filing content
Satellos Bioscience announced that its lead drug candidate, formerly known as SAT-3247, has been assigned the International Nonproprietary Name 'forazapadin'.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…